You have 9 free searches left this month | for more free features.

Retinal Atrophy

Showing 1 - 25 of 3,346

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cellular Scale Measures of Short-Term Retinal Atrophy

Recruiting
  • Pentosan Polysulfate Sodium Maculopathy
  • +4 more
  • Adaptive optics imaging
  • Bloomington, Indiana
    Indiana University School of Optometry
Dec 1, 2022

Neurodegenerative Process Within Visual Ways In Multiple

Completed
  • Multiple Sclerosis
    • Lille, France
      Hôpital Roger Salengro, CHRU
    Sep 20, 2022

    Age-Related Macular Degeneration Trial run by the NEI (iPSC-derived RPE/PGLA transplantation)

    Recruiting
    • Age-Related Macular Degeneration
    • iPSC-derived RPE/PLGA transplantation
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 28, 2023

    Geographic Atrophy Insights (i-GAIN) Natural History Study

    Recruiting
    • Dry Age-related Macular Degeneration
    • +6 more
      • Belfast, United Kingdom
      • +11 more
      Mar 22, 2023

      Retinal Disease, Age-Related Macular Degeneration, Retinitis Pigmentosa Trial in Westport, Coral Springs, Dubai (Arm 1)

      Recruiting
      • Retinal Disease
      • +17 more
      • Arm 1
      • Westport, Connecticut
      • +2 more
      Nov 25, 2022

      Geographic Atrophy, Macular Degeneration Trial in United States (JNJ-81201887, Prednisone, Placebo)

      Recruiting
      • Geographic Atrophy
      • Macular Degeneration
      • Phoenix, Arizona
      • +3 more
      Mar 31, 2023

      Geographic Atrophy Trial in United States (RO7303359)

      Active, not recruiting
      • Geographic Atrophy
      • Encino, California
      • +12 more
      Dec 12, 2022

      High Resolution Retinal Imaging

      Recruiting
      • Stargardts
      • +4 more
      • Retinal imaging
      • Philadelphia, Pennsylvania
        University of Pennsylvania
      Jan 26, 2022

      Ischemic Optic Neuropathy, Branch Retinal Artery Occlusion, Hemianopia Trial in Iowa City (LSFG-NAVI)

      Recruiting
      • Ischemic Optic Neuropathy
      • +4 more
      • LSFG-NAVI
      • Iowa City, Iowa
        University of Iowa Department of Ophthalmology
      Jul 4, 2022

      Age-related Macular Degeneration Trial in Israel, United States (OpRegen)

      Completed
      • Age-Related Macular Degeneration
      • OpRegen
      • (no location specified)
      Nov 1, 2022

      Dry Age-related Macular Degeneration, Macular Degeneration, Retinal Disease Trial in United Kingdom, United States (GT005)

      Recruiting
      • Dry Age-related Macular Degeneration
      • +6 more
      • GT005
      • Saint Petersburg, Florida
      • +12 more
      Dec 21, 2021

      Macular Degeneration, Age-Related, Geographic Atrophy Trial in United States (FHTR2163)

      Terminated
      • Macular Degeneration, Age-Related
      • Geographic Atrophy
      • Bakersfield, California
      • +51 more
      Nov 22, 2022

      Atrophy of Macula GCC by OCT and Whole Brain Atrophy by MRI to

      Active, not recruiting
      • Multiple Sclerosis
      • Brain MRI
      • +2 more
      • Nîmes, France
        CHU de Nimes
      Jan 6, 2022

      Multiple Eye Fundus Diseases From Color Fundus Photograph

      Completed
      • Diabetic Retinopathy
      • +12 more
      • Software assisted imaging diagnosis
      • BeiJing, Beijing, China
      • +4 more
      Dec 28, 2021

      Age-Related Maculopathy, Age-Related Maculopathies, Eye Diseases Trial in United States (RN6G, Placebo)

      Completed
      • Age-Related Maculopathy
      • +4 more
      • RN6G
      • Placebo
      • Campbell, California
      • +23 more
      May 10, 2022

      Macular Degeneration Trial in United Kingdom, United States (BI 754132)

      Terminated
      • Macular Degeneration
      • BI 754132
      • Beverly Hills, California
      • +12 more
      Aug 23, 2022

      Geographic Atrophy Trial in United States (ORACEA®, Placebo)

      Completed
      • Geographic Atrophy
      • Glendale, California
      • +36 more
      Nov 3, 2022

      Eye Diseases, Retinitis Pigmentosa, Glaucoma Trial in St. John's (AlloRx)

      Recruiting
      • Eye Diseases
      • +6 more
      • AlloRx
      • St. John's, Antigua and Barbuda
        Medical Surgical Associates Center
      Jan 4, 2022

      Optical Coherence Tomography, Optical Coherence Tomography Angiography, Retinal Thickening Trial in Amiens (Optical coherence

      Recruiting
      • Optical Coherence Tomography
      • +7 more
      • Optical coherence tomography (OCT)
      • Optical coherence tomograpohy angiography (OCTA)
      • Amiens, France
        CHU Amiens
      Mar 17, 2021

      Dry Age-related Macular Degeneration, Geographic Atrophy, Macular Degeneration Trial in United States (GEM103)

      Terminated
      • Dry Age-related Macular Degeneration
      • +4 more
      • Phoenix, Arizona
      • +28 more
      Mar 22, 2022

      Macular Degeneration, Dry, Primary Open-angle Glaucoma Trial in Vienna (White light stimulation)

      Recruiting
      • Macular Degeneration, Dry
      • Primary Open-angle Glaucoma
      • White light stimulation
      • Vienna, Austria
        Medical University of Vienna, Department of Clinical Pharmacolog
      Sep 6, 2021

      Age-Related Macular Degeneration, Geographic Atrophy Trial in United States (smaller incision, new generation implantable

      Recruiting
      • Age-Related Macular Degeneration
      • Geographic Atrophy
      • smaller incision, new generation implantable miniature telescope (SING-IMT)
      • Pasadena, California
      • +7 more
      Aug 5, 2022

      Global Atrophie Biomarker Evaluation Study (GABiE)

      Terminated
      • Age-related Macular Degeneration
      • Diagnostics
      • Boston, Massachusetts
      • +1 more
      Apr 29, 2021

      Dry Age-related Macular Degeneration, Geographic Atrophy, Macular Degeneration Trial in United States (GEM103)

      Completed
      • Dry Age-related Macular Degeneration
      • +4 more
      • GEM103
      • Phoenix, Arizona
      • +11 more
      Feb 9, 2021

      Dry Age-related Macular Degeneration Trial in Worldwide (GT005: Medium Dose, GT005: High Dose)

      Active, not recruiting
      • Dry Age-related Macular Degeneration
      • GT005: Medium Dose
      • GT005: High Dose
      • Phoenix, Arizona
      • +61 more
      Dec 14, 2022